As a global leader in Molecular Diagnostics and Women’s Health, Hologic | Gen-Probe is the only company with two FDA-approved and CE-marked HPV Assays: APTIMA HPV and Cervista HPV HR

•	The APTIMA HPV assay reimbursed according to EBM code 30820 and 30859
•	The APTIMA HPV assay now available for diagnostics according to S2k guideline of DGGG
•	Clinical validation according to the guidelines by Meijer et al. Int J Cancer, 2009
•	The APTIMA HPV assay runs on the fully automated TIGRIS® or PANTHER® instrument platforms
•	The APTIMA HPV assay is a second generation HPV assay that provides:
	• mRNA detection of the oncogenes E6/E7 • Coverage of the 14 most prevalent high risk HPV types • Proven performance in multiple clinical trials (Arbyn et al. Int J Cancer, 2013)   • High sensitivity for detecting cervical disease (CIN2+) • Improved specificity to reduce the number of clinically false positive results